Robert A. Bradway

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Thousand Oaks, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Robert A. Bradway
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert A. Bradway

Form 4 holding Chairman, CEO and President, Director

AMGEN INC

Security class
Common Stock
Shares / value
505,160
Estimated value
$177,740,546
Report date
07 May 2026
Price
$351.85
Ownership
Direct
Form 4 holding Chairman, CEO and President, Director

AMGEN INC

Security class
Nqso (Right to Buy)
Shares / value
79,176
Estimated value
$23,269,198
Report date
05 May 2026
Price
$270.44
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chairman, CEO and President, Director

AMGEN INC

Security class
Common Stock
Shares / value
60,060
Estimated value
$21,132,111
Report date
07 May 2026
Price
$351.85
Ownership
By GRAT
Form 4 holding Chairman, CEO and President, Director

AMGEN INC

Security class
Common Stock
Shares / value
60,060
Estimated value
$21,132,111
Report date
07 May 2026
Price
$351.85
Ownership
By Spousal GRAT
Form 4 holding Chairman, CEO and President, Director

AMGEN INC

Security class
Common Stock
Shares / value
29,940
Estimated value
$10,534,389
Report date
07 May 2026
Price
$351.85
Ownership
By Spouse
Form 4 holding Director

BOEING CO

Security class
Phantom Stock Units
Shares / value
15,877
Estimated value
$2,381,897
Report date
01 Apr 2026
Price
$167.60
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert A. Bradway

4 AMGN

AMGEN INC

Report period
06 May 2025
Transactions
2
Transaction value
+$23,269,198
Accepted by SEC
08 May 2025, 21:23
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
02 May 2025
Transactions
2
Transaction value
-$1,371,509
Accepted by SEC
06 May 2025, 20:05
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
30 Apr 2025
Transactions
1
Transaction value
-$734,097
Accepted by SEC
02 May 2025, 21:23
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
17 Mar 2025
Transactions
1
Transaction value
-$4,032,115
Accepted by SEC
19 Mar 2025, 20:15
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
07 May 2024
Transactions
2
Transaction value
+$23,386,463
Accepted by SEC
09 May 2024, 18:58
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
05 May 2024
Transactions
1
Transaction value
-$691,064
Accepted by SEC
07 May 2024, 20:30
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
02 May 2024
Transactions
1
Transaction value
-$636,287
Accepted by SEC
06 May 2024, 20:23
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
30 Apr 2024
Transactions
1
Transaction value
-$630,699
Accepted by SEC
01 May 2024, 19:50
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
18 Mar 2024
Transactions
1
Transaction value
-$5,527,967
Accepted by SEC
20 Mar 2024, 19:58
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
05 May 2023
Transactions
1
Transaction value
-$483,027
Accepted by SEC
09 May 2023, 19:11
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
02 May 2023
Transactions
3
Transaction value
-$675,582
Accepted by SEC
04 May 2023, 20:23
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
30 Apr 2023
Transactions
1
Transaction value
-$529,346
Accepted by SEC
02 May 2023, 20:15
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
17 Mar 2023
Transactions
1
Transaction value
-$3,277,177
Accepted by SEC
20 Mar 2023, 18:42
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
05 May 2022
Transactions
1
Transaction value
-$476,214
Accepted by SEC
09 May 2022, 19:00
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
02 May 2022
Transactions
3
Transaction value
-$621,637
Accepted by SEC
04 May 2022, 19:44
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
27 Apr 2022
Transactions
1
Transaction value
-$636,419
Accepted by SEC
29 Apr 2022, 18:37
Role
Chairman, CEO and President, Director
Next action
Open filing details
4 AMGN

AMGEN INC

Report period
18 Mar 2022
Transactions
1
Transaction value
-$4,123,069
Accepted by SEC
22 Mar 2022, 17:37
Role
Chairman, CEO and President, Director
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .